Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases.

ABSTRACT: Mucosal histological activity is increasingly valued as a treatment endpoint in inflammatory bowel diseases (IBD). In the Asia Pacific region, the utility and acceptability of IBD histology as a treatment endpoint are uncertain due to the heterogeneity of IBD prevalence, resourcing and level of knowledge among practitioners. There is an opportunity to engage clinicians to harmonise histology reporting and collaborate with pathologists in this field. We aimed to develop consensus statements through anonymous voting on histological features, processing, reporting and relevance to treatment outcomes in IBD, including ulcerative colitis (UC) and Crohn's disease (CD). The consensus document was developed through a comprehensive literature review, followed by a deliberation process among experts

SUBMITTER: Leong RW 

PROVIDER: S-EPMC12365448 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature